These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 169839)

  • 21. Oncogenic activity of feline fibrosarcoma virus in newborn pigs.
    Pearsn LD; Snyder SP; Aldrich CD
    Am J Vet Res; 1973 Mar; 34(3):405-9. PubMed ID: 4348004
    [No Abstract]   [Full Text] [Related]  

  • 22. Pathogenesis of experimental feline leukemia virus infection.
    Rojko JL; Hoover EA; Mathes LE; Olsen RG; Schaller JP
    J Natl Cancer Inst; 1979 Sep; 63(3):759-68. PubMed ID: 224237
    [No Abstract]   [Full Text] [Related]  

  • 23. Circulating levels of feline leukemia and sarcoma viruses and fibrosarcoma regression in persistently viremic cats.
    de Noronha F; Grant CK; Lutz H; Keyes A; Rowston W
    Cancer Res; 1983 Apr; 43(4):1663-8. PubMed ID: 6299527
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on FeSV induced sarcomata in sheep with particular reference to the regional lymphatic system.
    Hall JG; Scollay RG; Birbeck MS; Theilen GH
    Br J Cancer; 1975 Dec; 32(6):639-59. PubMed ID: 175813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of a tumour-specific antigen on the surface of feline lymphosarcoma cells.
    Snyder HW; Hardy WD; Zuckerman EE; Fleissner E
    Nature; 1978 Oct; 275(5681):656-8. PubMed ID: 212681
    [No Abstract]   [Full Text] [Related]  

  • 26. Syncytial giant cell focus assay for viruses derived from feline leukemia and a simian sarcoma.
    Rangan SR; Ueberhorst PJ; Wong MC
    Proc Soc Exp Biol Med; 1973 Apr; 142(4):1077-82. PubMed ID: 4348580
    [No Abstract]   [Full Text] [Related]  

  • 27. Vaccination against feline leukaemia virus using a cell membrane antigen system.
    Jarrett W; Jarrett O; Mackey L; Laird H; Hood C; Hay D
    Int J Cancer; 1975 Jul; 16(1):134-41. PubMed ID: 170211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immuno-prophylaxis and -therapy of C-type oncorna viral diseases in mice and cats.
    Schäfer W; Bolognesi DP; de Noronha F; Fischinger PJ; Hunsmann G; Ihle JN; Moenning V; Schwarz H; Thiel HJ
    Med Microbiol Immunol; 1977; 164(1-3):217-29. PubMed ID: 202852
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sarcomas in syrian hamster, induced by an oncorna virus and cellfree transmissible (author's transl)].
    Graffi A; Bender E; Schramm T; Graffi I; Niezabitowski A; Schneiders F
    Arch Geschwulstforsch; 1976; 46(2):77-84. PubMed ID: 962507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between humoral antibodies and the failure to develop progressive tumors in cats injected with feline sarcoma virus (FSV).
    Essex M; Snyder SP; Klein G
    Bibl Haematol; 1973; 39():771-7. PubMed ID: 4360194
    [No Abstract]   [Full Text] [Related]  

  • 31. Location of feline leukemia-sarcoma group-specific antigen in infected human tissue culture cells.
    Ubertini TR
    Infect Immun; 1972 Mar; 5(3):400-5. PubMed ID: 4344220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests.
    Sarma PS; Log T
    Virology; 1973 Jul; 54(1):160-9. PubMed ID: 4351607
    [No Abstract]   [Full Text] [Related]  

  • 33. Feline oncornavirus-associated cell membrane antigen: expression in transformed nonproducer mink cells.
    Sliski AH; Essex M; Meyer C; Todaro G
    Science; 1977 Jun; 196(4296):1336-9. PubMed ID: 194310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The feline oncornavirus-associated cell membrane antigen (FOCMA) is related to, but distinguishable from, FeLV-C gp70.
    Snyder HW; Singhal MC; Zuckerman EE; Jones FR; Hardy WD
    Virology; 1983 Dec; 131(2):315-27. PubMed ID: 6318434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On the oncogenicity of simian adenoviruses for hamsters].
    Tsetlin EM; Dodnova NN; Al'tshteĭn AD; Vasil'eva NN; Levenbuk IS; Chigirinskiĭ AE
    Vopr Onkol; 1968; 14(12):44-50. PubMed ID: 4978962
    [No Abstract]   [Full Text] [Related]  

  • 36. Feline oncornavirus-associated cell membrane antigen. VI. Cytotoxic antibody in cats exposed to feline leukemia virus.
    Mathes LE; Yohn DS; Hoover EA; Essex M; Schaller JP; Olsen RG
    J Natl Cancer Inst; 1976 Jun; 56(6):1197-200. PubMed ID: 186623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor induction in squirrel monkeys by the ST strain of feline sarcoma virus.
    Rabin H; Theilen GH; Sarma PS; Dungworth DL; Nelson-Rees WA; Cooper RW
    J Natl Cancer Inst; 1972 Aug; 49(2):441-50. PubMed ID: 4342616
    [No Abstract]   [Full Text] [Related]  

  • 38. Experimental oncornavirus vaccines in the cat.
    Yohn DS; Olsen RG; Schaller JP; Hoover EA; Mathes LE; Heding L; Davis GW
    Cancer Res; 1976 Feb; 36(2 pt 2):646-51. PubMed ID: 943234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feline oncovirus-associated cell membrane antigen and feline leukemia virus group-specific antigen expression in bone marrow and serum.
    Rice JB; Olsen RG
    J Natl Cancer Inst; 1981 Apr; 66(4):737-43. PubMed ID: 6262553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential host range of viruses of feline leukemia-sarcoma complex.
    Sarma PS; Log T; Jain D; Hill PR; Huebner RJ
    Virology; 1975 Apr; 64(2):438-46. PubMed ID: 166488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.